MyFinsight
Home
Blog
About
Contact
Download
Download image
Net increase in cash
and cash...
-$5,051,473
Stock-based compensation
expense
$1,156,495
Prepaid expenses and
other assets
-$764,455
Accrued expenses
$516,590
Amortization of debt discount
$448,837
Accounts payable
$75,904
Finance lease
depreciation expense
$9,670
Depreciation expense
$5,459
Proceeds from issuance of
common stock from...
$833,371
Net cash used in
operating activities
-$4,371,646
Net cash provided by
financing activities
-$679,827
Canceled cashflow
$2,977,410
Canceled cashflow
$833,371
Interest income
$186,814
Net loss
-$7,349,056
Loan principal
repayment
$1,500,000
Canceled cashflow
$186,814
Payments of finance lease
obligations
$13,198
Total operating
expenses
$6,521,087
Interest expense
$1,014,783
Back
Back
Cash Flow
PDS Biotechnology Corp (PDSB)
PDS Biotechnology Corp (PDSB)
source: myfinsight.com